FWIW, I agree that he should be replaced. Just no
Post# of 148187
(Total Views: 289)
Posted On: 10/23/2019 2:03:50 PM
Re: the lawman #9868
FWIW, I agree that he should be replaced. Just not right now.
That being said, I invested in this stock knowing that he and MM were "C" executives. I believed the drug was strong enough to carry the company through to BO. Time will tell. It might be my worst investment decision ever.
Many people are missing the point. Nader has progressed the pipeline -- no doubt. And he picked the drug out of the dustbin. But he doesn't know the first thing about communicating to the investment community. And he doesn't know how to raise money. So, he has been raising money from high-net worth individuals to the tune of $210M at discounts to market. A seasoned executive would have raised that same money from institutional investors (IIs) and much higher valuations (and ever increasing valuations) and thus significantly reduced dilution. And building companies is like social climbing in groups of monkeys. You get IIs who are connected, and they connect you to other connected people. Soon, those in the "know" are buying and supporting your stock. Then the bulge-bracket iBanks get excited. This becomes a whole positive snowball.
My best guess is that Nader approached institutional investors and they either didn't invest (their first criteria is an "A" executive team) or said they would only invest if a seasoned CEO and CFO were put into place. And Nader wouldn't go for that (even though it would have been in his best financial interest).
The other issue we have is that Jordan N. and Scott K. are die-hard NP supporters. And the BOD is far too thin right now. So, effectively NP has inside control of the BOD. So, he is not going anywhere.
So, will we get to the end game? I believe so. But we will own 30-50% less of the company than we should have had we had a seasoned CEO and CFO.
That being said, I invested in this stock knowing that he and MM were "C" executives. I believed the drug was strong enough to carry the company through to BO. Time will tell. It might be my worst investment decision ever.
Many people are missing the point. Nader has progressed the pipeline -- no doubt. And he picked the drug out of the dustbin. But he doesn't know the first thing about communicating to the investment community. And he doesn't know how to raise money. So, he has been raising money from high-net worth individuals to the tune of $210M at discounts to market. A seasoned executive would have raised that same money from institutional investors (IIs) and much higher valuations (and ever increasing valuations) and thus significantly reduced dilution. And building companies is like social climbing in groups of monkeys. You get IIs who are connected, and they connect you to other connected people. Soon, those in the "know" are buying and supporting your stock. Then the bulge-bracket iBanks get excited. This becomes a whole positive snowball.
My best guess is that Nader approached institutional investors and they either didn't invest (their first criteria is an "A" executive team) or said they would only invest if a seasoned CEO and CFO were put into place. And Nader wouldn't go for that (even though it would have been in his best financial interest).
The other issue we have is that Jordan N. and Scott K. are die-hard NP supporters. And the BOD is far too thin right now. So, effectively NP has inside control of the BOD. So, he is not going anywhere.
So, will we get to the end game? I believe so. But we will own 30-50% less of the company than we should have had we had a seasoned CEO and CFO.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼